{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:01:25Z","timestamp":1791054085282,"version":"4.1.0"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:00:00Z","timestamp":1736035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["764860"],"award-info":[{"award-number":["764860"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.nbd.2025.106797","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T03:19:42Z","timestamp":1736219982000},"page":"106797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Anxiety-like behavior and altered hippocampal activity in a transgenic mouse model of Fabry disease"],"prefix":"10.1016","volume":"205","author":[{"given":"Kai","family":"Kummer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeiny Luna","family":"Choconta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Luise","family":"Edenhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Bajpai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopuraja","family":"Dharmalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Kalpachidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Kress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.nbd.2025.106797_bb0005","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1161\/01.STR.32.7.1559","article-title":"Enhanced endothelium-dependent vasodilation in Fabry disease","volume":"32","author":"Altarescu","year":"2001","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.nbd.2025.106797_bb0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12974-020-01892-4","article-title":"Three-dimensional morphometric analysis reveals time-dependent structural changes in microglia and astrocytes in the central amygdala and hypothalamic paraventricular nucleus of heart failure rats","volume":"17","author":"Althammer","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2025.106797_bb0015","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3389\/fphys.2016.00573","article-title":"Fatty acid regulation of voltage- and ligand-gated Ion Channel function","volume":"7","author":"Antollini","year":"2016","journal-title":"Front. Physiol."},{"issue":"11","key":"10.1016\/j.nbd.2025.106797_bb0020","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1016\/j.celrep.2017.11.050","article-title":"A single-cell RNA sequencing study reveals cellular and molecular dynamics of the hippocampal neurogenic niche","volume":"21","author":"Artegiani","year":"2017","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.nbd.2025.106797_bb0025","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00428-007-0468-6","article-title":"Cellular and tissue localization of globotriaosylceramide in Fabry disease","volume":"451","author":"Askari","year":"2007","journal-title":"Virchows Arch."},{"issue":"6","key":"10.1016\/j.nbd.2025.106797_bb0030","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0092-8674(95)90010-1","article-title":"Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal LTP in the range of the theta frequency","volume":"81","author":"Bach","year":"1995","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.nbd.2025.106797_bb0035","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ajpath.2014.11.004","article-title":"Alpha-galactosidase a knockout mice: progressive organ pathology resembles the type 2 later-onset phenotype of Fabry disease","volume":"185","author":"Bangari","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.nbd.2025.106797_bb0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13024-020-00408-1","article-title":"Glycosphingolipids and neuroinflammation in Parkinson\u2019s disease","volume":"15","author":"Belarbi","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2025.106797_bb0045","first-page":"11","article-title":"Neuroinflammation in neuronopathic Gaucher disease: role of microglia and NK cells, biomarkers, and response to substrate reduction therapy","author":"Boddupalli","year":"2022","journal-title":"Elife"},{"issue":"11","key":"10.1016\/j.nbd.2025.106797_bb0050","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157782","article-title":"Accumulation of \u03b1-synuclein mediates podocyte injury in Fabry nephropathy","volume":"133","author":"Braun","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2025.106797_bb0055","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1046\/j.1523-1755.63.s84.5.x","article-title":"Fabry disease: diagnosis and treatment","volume":"84","author":"Breunig","year":"2003","journal-title":"Kidney Int. Suppl."},{"issue":"5","key":"10.1016\/j.nbd.2025.106797_bb0060","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1097\/j.pain.0000000000002152","article-title":"Fabry disease pain: patient and preclinical parallels","volume":"162","author":"Burand","year":"2021","journal-title":"Pain"},{"issue":"21","key":"10.1016\/j.nbd.2025.106797_bb0065","doi-asserted-by":"crossref","first-page":"7364","DOI":"10.1073\/pnas.82.21.7364","article-title":"Fabry disease: isolation of a cDNA clone encoding human alpha-galactosidase a","volume":"82","author":"Calhoun","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.nbd.2025.106797_bb0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12979-023-00346-8","article-title":"Age-related neuroimmune signatures in dorsal root ganglia of a Fabry disease mouse model","volume":"20","author":"Choconta","year":"2023","journal-title":"Immun. Ageing"},{"issue":"4","key":"10.1016\/j.nbd.2025.106797_bb0075","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/hbm.23949","article-title":"Default mode network modifications in Fabry disease: a resting-state fMRI study with structural correlations","volume":"39","author":"Cocozza","year":"2018","journal-title":"Hum. Brain Mapp."},{"issue":"1","key":"10.1016\/j.nbd.2025.106797_bb0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000502909","article-title":"Aging in Fabry disease: role of telomere length, telomerase activity, and kidney disease","volume":"144","author":"Cokan Vujkovac","year":"2020","journal-title":"Nephron"},{"issue":"6","key":"10.1016\/j.nbd.2025.106797_bb0085","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10545-007-0708-6","article-title":"Depression in adults with Fabry disease: a common and under-diagnosed problem","volume":"30","author":"Cole","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.nbd.2025.106797_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065246","article-title":"Fabry disease and central nervous system involvement: from big to small, from brain to synapse","volume":"24","author":"Cort\u00e9s-Saladelafont","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.nbd.2025.106797_bb0095","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12974-019-1672-4","article-title":"Unique molecular signature in mucolipidosis type IV microglia","volume":"16","author":"Cougnoux","year":"2019","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.nbd.2025.106797_bb0100","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1212\/WNL.50.6.1746","article-title":"Quantitative analysis of cerebral vasculopathy in patients with Fabry disease","volume":"50","author":"Crutchfield","year":"1998","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nbd.2025.106797_bb0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/1531-8249(200002)47:2<229::AID-ANA13>3.0.CO;2-T","article-title":"Profile of endothelial and leukocyte activation in Fabry patients","volume":"47","author":"DeGraba","year":"2000","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.nbd.2025.106797_bb0110","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/jnen\/nlz139","article-title":"Fabry disease with concomitant Lewy body disease","volume":"79","author":"Del Tredici","year":"2020","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"4","key":"10.1016\/j.nbd.2025.106797_bb0115","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.kint.2023.06.029","article-title":"Systems analyses of the Fabry kidney transcriptome and its response to enzyme replacement therapy identified and cross-validated enzyme replacement therapy-resistant targets amenable to drug repurposing","volume":"104","author":"Delaleu","year":"2023","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.nbd.2025.106797_bb0120","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/cns.12674","article-title":"Cpne5 is involved in regulating rodent anxiety level","volume":"23","author":"Ding","year":"2017","journal-title":"CNS Neurosci. Ther."},{"issue":"7","key":"10.1016\/j.nbd.2025.106797_bb0125","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1523\/JNEUROSCI.4762-12.2013","article-title":"The disruption of Celf6, a gene identified by translational profiling of serotonergic neurons, results in autism-related behaviors","volume":"33","author":"Dougherty","year":"2013","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.nbd.2025.106797_bb0130","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF01606034","article-title":"Cardiocyte storage and hypertrophy as a sole manifestation of Fabry\u2019s disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy","volume":"417","author":"Elleder","year":"1990","journal-title":"Virchows Arch. A Pathol. Anat. Histopathol."},{"issue":"2","key":"10.1016\/j.nbd.2025.106797_bb0135","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10545-011-9390-9","article-title":"Hippocampal atrophy as a surrogate of neuronal involvement in Fabry disease","volume":"35","author":"Fellgiebel","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.nbd.2025.106797_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e14522","article-title":"Comparative analysis between open field and elevated plus maze tests as a method for evaluating anxiety-like behavior in mice","volume":"9","author":"Figueiredo Cerqueira","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.nbd.2025.106797_bb0145","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13059-015-0844-5","article-title":"MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data","volume":"16","author":"Finak","year":"2015","journal-title":"Genome Biol."},{"issue":"4","key":"10.1016\/j.nbd.2025.106797_bb0150","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac187","article-title":"Structural disconnection and functional reorganization in Fabry disease: a multimodal MRI study","volume":"4","author":"Gabusi","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.nbd.2025.106797_bb0155","series-title":"Fabry Disease: Perspectives from 5 Years of FOS","year":"2006"},{"issue":"Pt 9","key":"10.1016\/j.nbd.2025.106797_bb0160","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/brain\/awh546","article-title":"Megadolichobasilar anomaly with thrombosis in a family with Fabry\u2019s disease and a novel mutation in the alpha-galactosidase a gene","volume":"128","author":"Garzuly","year":"2005","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.nbd.2025.106797_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00210-018-1589-y","article-title":"Assessment of spatial learning and memory in the Barnes maze task in rodents-methodological consideration","volume":"392","author":"Gawel","year":"2019","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.nbd.2025.106797_bb0170","first-page":"7","article-title":"Mild myelin disruption elicits early alteration in behavior and proliferation in the subventricular zone","author":"Gould","year":"2018","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.nbd.2025.106797_bb0175","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.neuron.2022.11.017","article-title":"Dicreasing mutant ATXN1 nuclear localization improves a spectrum of SCA1-like phenotypes and brain region transcriptomic profiles","volume":"111","author":"Handler","year":"2023","journal-title":"Neuron"},{"issue":"13","key":"10.1016\/j.nbd.2025.106797_bb0180","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.nbd.2025.106797_bb0185","doi-asserted-by":"crossref","first-page":"e3560","DOI":"10.1002\/jgm.3560","article-title":"Therapeutic strategy for Fabry disease by intravenous administration of adeno-associated virus 2 or 9 in \u03b1-galactosidase A-deficient mice","volume":"25","author":"Hayashi","year":"2023","journal-title":"J. Gene Med."},{"issue":"2","key":"10.1016\/j.nbd.2025.106797_bb0190","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000520145","article-title":"Autopsy findings of heterozygous Fabry disease with the severe phenotype: a case report","volume":"146","author":"Hiratsuka","year":"2022","journal-title":"Nephron"},{"issue":"6","key":"10.1016\/j.nbd.2025.106797_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180601","article-title":"Affective and cognitive behavior in the alpha-galactosidase a deficient mouse model of Fabry disease","volume":"12","author":"Hofmann","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.nbd.2025.106797_bb0200","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2144\/btn-2020-0152","article-title":"Injection of Evans blue dye to fluorescently label and image intact vasculature","volume":"70","author":"Honeycutt","year":"2021","journal-title":"Biotechniques"},{"key":"10.1016\/j.nbd.2025.106797_bb0205","article-title":"Massive accumulation of globotriaosylceramide in various tissues from a Fabry patient with a high antibody titer against alpha-galactosidase a after 6 years of enzyme replacement therapy","volume":"24","author":"Hongo","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"21","key":"10.1016\/j.nbd.2025.106797_bb0210","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/bioinformatics\/btw376","article-title":"Unbiased classification of spatial strategies in the Barnes maze","volume":"32","author":"Illouz","year":"2016","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.nbd.2025.106797_bb0215","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1212\/CPJ.0000000000000268","article-title":"Clinical utility of seropositive voltage-gated potassium channel-complex antibody","volume":"6","author":"Jammoul","year":"2016","journal-title":"Neurol. Clin. Pract."},{"issue":"11","key":"10.1016\/j.nbd.2025.106797_bb0220","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1212\/01.wnl.0000247278.88077.09","article-title":"Myeloperoxidase predicts risk of vasculopathic events in hemizgygous males with Fabry disease","volume":"67","author":"Kaneski","year":"2006","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.nbd.2025.106797_bb0225","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/ana.410230513","article-title":"Nervous system involvement in Fabry\u2019s disease: clinicopathological and biochemical correlation","volume":"23","author":"Kaye","year":"1988","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2025.106797_bb0230","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/mt.2009.220","article-title":"The pharmacological chaperone 1-deoxygalactonojirimycin reduces tissue globotriaosylceramide levels in a mouse model of Fabry disease","volume":"18","author":"Khanna","year":"2010","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.nbd.2025.106797_bb0235","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.neuron.2012.12.038","article-title":"Differential control of learning and anxiety along the dorsoventral axis of the dentate gyrus","volume":"77","author":"Kheirbek","year":"2013","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.nbd.2025.106797_bb0240","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/jhg.2015.123","article-title":"Unravelling the mechanism of action of enzyme replacement therapy in Fabry disease","volume":"61","author":"Ko","year":"2016","journal-title":"J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.nbd.2025.106797_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/biom11020271","article-title":"Fabry disease: molecular basis, pathophysiology, diagnostics and potential therapeutic directions","volume":"11","author":"Kok","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.nbd.2025.106797_bb0250","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/STROKEAHA.114.006283","article-title":"Cerebrovascular involvement in Fabry disease: current status of knowledge","volume":"46","author":"Kolodny","year":"2015","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.nbd.2025.106797_bb0255","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12883-019-1348-9","article-title":"Central nervous system vasculopathy caused by Fabry disease: a case report","volume":"19","author":"Kong","year":"2019","journal-title":"BMC Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2025.106797_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000503290","article-title":"Fabry disease: a new model of premature ageing?","volume":"144","author":"Kooman","year":"2020","journal-title":"Nephron"},{"issue":"1","key":"10.1016\/j.nbd.2025.106797_bb0265","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41598-018-37320-0","article-title":"Predictors of objective cognitive impairment and subjective cognitive complaints in patients with Fabry disease","volume":"9","author":"Korver","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.nbd.2025.106797_bb0270","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10571-017-0510-4","article-title":"BDNF: a key factor with multipotent impact on brain signaling and synaptic plasticity","volume":"38","author":"Kowianski","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"issue":"1\u20132","key":"10.1016\/j.nbd.2025.106797_bb0275","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000370314","article-title":"Social interaction and cocaine conditioning in mice increase spontaneous spike frequency in the nucleus accumbens or septal nuclei as revealed by multielectrode array recordings","volume":"95","author":"Kummer","year":"2015","journal-title":"Pharmacology"},{"key":"10.1016\/j.nbd.2025.106797_bb0280","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3389\/fnmol.2017.00449","article-title":"Signatures of altered gene expression in dorsal root ganglia of a Fabry disease mouse model","volume":"10","author":"Kummer","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2025.106797_bb0285","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fnmol.2018.00201","article-title":"Altered gene expression in prefrontal cortex of a Fabry disease mouse model","volume":"11","author":"Kummer","year":"2018","journal-title":"Front. Mol. Neurosci."},{"issue":"10","key":"10.1016\/j.nbd.2025.106797_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108641","article-title":"Pain related channels are differentially expressed in neuronal and non-neuronal cells of glabrous skin of fabry knockout male mice","volume":"9","author":"Lakoma","year":"2014","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.nbd.2025.106797_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184349","article-title":"Inhibition of mitochondrial complex I impairs release of alpha-galactosidase by Jurkat cells","volume":"20","author":"Lambert","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl. 3","key":"10.1016\/j.nbd.2025.106797_bb0300","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1007\/s10545-009-9025-6","article-title":"Social-adaptive and psychological functioning of patients affected by Fabry disease","volume":"33","author":"Laney","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"8","key":"10.1016\/j.nbd.2025.106797_bb0310","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/emboj\/19.8.1784","article-title":"Polyunsaturated fatty acids are potent neuroprotectors","volume":"19","author":"Lauritzen","year":"2000","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.nbd.2025.106797_bb0315","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1523\/JNEUROSCI.2405-20.2020","article-title":"Heterogeneity of age-related neural hyperactivity along the CA3 transverse Axis","volume":"41","author":"Lee","year":"2021","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.nbd.2025.106797_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137603","article-title":"Eight-year follow-up of neuropsychiatric symptoms and brain structural changes in Fabry disease","volume":"10","author":"Lelieveld","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.nbd.2025.106797_bb0325","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s40265-021-01486-1","article-title":"Fabry disease: the current treatment landscape","volume":"81","author":"Lenders","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.nbd.2025.106797_bb0330","doi-asserted-by":"crossref","first-page":"1143905","DOI":"10.3389\/fmed.2023.1143905","article-title":"Urinary-derived extracellular vesicles reveal a distinct microRNA signature associated with the development and progression of Fabry nephropathy","volume":"10","author":"Levstek","year":"2023","journal-title":"Front. Med. (Lausanne)."},{"key":"10.1016\/j.nbd.2025.106797_bb0335","first-page":"9","article-title":"Supramammillary nucleus synchronizes with dentate gyrus to regulate spatial memory retrieval through glutamate release","author":"Li","year":"2020","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.nbd.2025.106797_bb0340","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12974-022-02447-5","article-title":"Single-cell transcriptomic analysis of the immune cell landscape in the aged mouse brain after ischemic stroke","volume":"19","author":"Li","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.nbd.2025.106797_bb0345","first-page":"1683","article-title":"Altered immune phenotypes in subjects with Fabry disease and responses to switching from agalsidase alfa to agalsidase beta","volume":"11","author":"Limgala","year":"2019","journal-title":"Am. J. Transl. Res."},{"issue":"5","key":"10.1016\/j.nbd.2025.106797_bb0350","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCGENETICS.109.862920","article-title":"High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population","volume":"2","author":"Lin","year":"2009","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"Suppl. 2","key":"10.1016\/j.nbd.2025.106797_bb0355","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1012447102358","article-title":"Natural history of Fabry disease in affected males and obligate carrier females","volume":"24","author":"MacDermot","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.nbd.2025.106797_bb0360","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/eurjhf\/hfq211","article-title":"Cardiac energy metabolism is disturbed in Fabry disease and improves with enzyme replacement therapy using recombinant human galactosidase a","volume":"13","author":"Machann","year":"2011","journal-title":"Eur. J. Heart Fail."},{"issue":"4","key":"10.1016\/j.nbd.2025.106797_bb0365","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1007\/s00429-015-1005-z","article-title":"The RNA-binding protein Celf6 is highly expressed in diencephalic nuclei and neuromodulatory cell populations of the mouse brain","volume":"221","author":"Maloney","year":"2016","journal-title":"Brain Struct. Funct."},{"issue":"7","key":"10.1016\/j.nbd.2025.106797_bb0370","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12593","article-title":"Loss of CELF6 RNA binding protein impairs cocaine conditioned place preference and contextual fear conditioning","volume":"18","author":"Maloney","year":"2019","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.nbd.2025.106797_bb0375","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jns.2018.10.009","article-title":"Brain MRI findings in children and adolescents with Fabry disease","volume":"395","author":"Marchesoni","year":"2018","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.nbd.2025.106797_bb0380","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00415-005-0020-z","article-title":"Diffuse structural and metabolic brain changes in Fabry disease","volume":"253","author":"Marino","year":"2006","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2025.106797_bb0385","first-page":"1","article-title":"Innate and adaptive immune response in Fabry disease","volume":"22","author":"Mauhin","year":"2015","journal-title":"JIMD Rep."},{"issue":"1","key":"10.1016\/j.nbd.2025.106797_bb0390","doi-asserted-by":"crossref","first-page":"8868","DOI":"10.1038\/s41598-018-27293-5","article-title":"Brain cell type specific gene expression and co-expression network architectures","volume":"8","author":"McKenzie","year":"2018","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.nbd.2025.106797_bb0395","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99171","article-title":"Neuropathic pain in a Fabry disease rat model","volume":"3","author":"Miller","year":"2018","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.nbd.2025.106797_bb0400","article-title":"Stroke and Fabry disease: a review of literature","volume":"12","author":"Mishra","year":"2020","journal-title":"Cureus"},{"issue":"1\u20132","key":"10.1016\/j.nbd.2025.106797_bb0405","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jns.2007.01.053","article-title":"The cerebral vasculopathy of Fabry disease","volume":"257","author":"Moore","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2025.106797_bb0410","article-title":"Neuropsychiatric symptoms and their association with sex, age, and enzyme replacement therapy in Fabry disease: a systematic review","volume":"13","author":"Mroczek","year":"2022","journal-title":"Front. Psychol."},{"issue":"4","key":"10.1016\/j.nbd.2025.106797_bb0415","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/jimd.12472","article-title":"Cognitive dysfunction and white matter hyperintensities in Fabry disease","volume":"45","author":"Murphy","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.nbd.2025.106797_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036373","article-title":"Globotriaosylsphingosine accumulation and not alpha-galactosidase-a deficiency causes endothelial dysfunction in Fabry disease","volume":"7","author":"Namdar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2025.106797_bb0425","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fneur.2017.00335","article-title":"Changes in ionic conductance signature of nociceptive neurons underlying Fabry disease phenotype","volume":"8","author":"Namer","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2025.106797_bb0430","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2051-5960-2-20","article-title":"Autophagy-lysosome pathway associated neuropathology and axonal degeneration in the brains of alpha-galactosidase A-deficient mice","volume":"2","author":"Nelson","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"issue":"3","key":"10.1016\/j.nbd.2025.106797_bb0435","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/jmedgenet-2020-107086","article-title":"Circular RNA-based biomarkers in blood of patients with Fabry disease and related phenotypes","volume":"59","author":"Nowak","year":"2022","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.nbd.2025.106797_bb0440","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fnsys.2016.00052","article-title":"Intrinsic hippocampal excitability changes of opposite signs and different origins in CA1 and CA3 pyramidal neurons underlie aging-related cognitive deficits","volume":"10","author":"Oh","year":"2016","journal-title":"Front. Syst. Neurosci."},{"issue":"6","key":"10.1016\/j.nbd.2025.106797_bb0445","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1073\/pnas.94.6.2540","article-title":"alpha-Galactosidase A deficient mice: a model of Fabry disease","volume":"94","author":"Ohshima","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.nbd.2025.106797_bb0450","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1073\/pnas.96.11.6423","article-title":"Aging accentuates and bone marrow transplantation ameliorates metabolic defects in Fabry disease mice","volume":"96","author":"Ohshima","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.nbd.2025.106797_bb0455","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1440-1789.2008.00883.x","article-title":"An autopsy case of Fabry disease with neuropathological investigation of the pathogenesis of associated dementia","volume":"28","author":"Okeda","year":"2008","journal-title":"Neuropathology"},{"issue":"3","key":"10.1016\/j.nbd.2025.106797_bb0460","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0166-2236(91)90069-7","article-title":"Direct regulation of ion channels by fatty acids","volume":"14","author":"Ordway","year":"1991","journal-title":"Trends Neurosci."},{"issue":"5","key":"10.1016\/j.nbd.2025.106797_bb0465","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00234-012-1131-8","article-title":"Diffusion tensor imaging and brain volumetry in Fabry disease patients","volume":"55","author":"Paavilainen","year":"2013","journal-title":"Neuroradiology"},{"issue":"2","key":"10.1016\/j.nbd.2025.106797_bb0470","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijcard.2009.03.045","article-title":"Association between cardiac energy metabolism and gain of left ventricular mass in Fabry disease","volume":"144","author":"Palecek","year":"2010","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.nbd.2025.106797_bb0475","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/jnr.20134","article-title":"Messenger RNA and protein expression analysis of voltage-gated potassium channels in the brain of Abeta(25-35)-treated rats","volume":"77","author":"Pan","year":"2004","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.nbd.2025.106797_bb0480","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/mol.107.034868","article-title":"Up-regulation and increased activity of KV3.4 channels and their accessory subunit MinK-related peptide 2 induced by amyloid peptide are involved in apoptotic neuronal death","volume":"72","author":"Pannaccione","year":"2007","journal-title":"Mol. Pharmacol."},{"issue":"15","key":"10.1016\/j.nbd.2025.106797_bb0485","article-title":"Early defects in mucopolysaccharidosis type IIIC disrupt excitatory synaptic transmission","volume":"6","author":"Para","year":"2021","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.nbd.2025.106797_bb0490","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1474-4422(09)70236-4","article-title":"Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis","volume":"8","author":"Pendlebury","year":"2009","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.nbd.2025.106797_bb0500","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.neurobiolaging.2005.09.038","article-title":"Amyloid beta peptide as a physiological modulator of neuronal \u2018A\u2019-type K+ current","volume":"27","author":"Plant","year":"2006","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.nbd.2025.106797_bb0505","doi-asserted-by":"crossref","DOI":"10.3390\/diseases9040072","article-title":"Survey about the quality of life of Italian patients with Fabry disease","volume":"9","author":"Polistena","year":"2021","journal-title":"Diseases"},{"issue":"17","key":"10.1016\/j.nbd.2025.106797_bb0510","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.4155\/bio-2016-0116","article-title":"Relative distribution of Gb3 isoforms\/analogs in NOD\/SCID\/Fabry mice tissues determined by tandem mass spectrometry","volume":"8","author":"Provencal","year":"2016","journal-title":"Bioanalysis"},{"issue":"1\u20132","key":"10.1016\/j.nbd.2025.106797_bb0515","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2011.03.020","article-title":"Brain MRI findings in patients with Fabry disease","volume":"305","author":"Reisin","year":"2011","journal-title":"J. Neurol. Sci."},{"issue":"12","key":"10.1016\/j.nbd.2025.106797_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108531","article-title":"CLIP and massively parallel functional analysis of CELF6 reveal a role in destabilizing synaptic gene mRNAs through interaction with 3\u2019 UTR elements","volume":"33","author":"Rieger","year":"2020","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.nbd.2025.106797_bb0525","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00431-003-1299-3","article-title":"The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents","volume":"162","author":"Ries","year":"2003","journal-title":"Eur. J. Pediatr."},{"issue":"1","key":"10.1016\/j.nbd.2025.106797_bb0530","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nbd.2008.09.001","article-title":"Neurophysiological, behavioral and morphological abnormalities in the Fabry knockout mice","volume":"33","author":"Rodrigues","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"9499","key":"10.1016\/j.nbd.2025.106797_bb0535","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/S0140-6736(05)67635-0","article-title":"Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study","volume":"366","author":"Rolfs","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2025.106797_bb0540","article-title":"Barnes maze testing strategies with small and large rodent models","volume":"84","author":"Rosenfeld","year":"2014","journal-title":"J. Vis. Exp."},{"issue":"3","key":"10.1016\/j.nbd.2025.106797_bb0545","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ymgme.2017.09.004","article-title":"Contribution of inflammatory pathways to Fabry disease pathogenesis","volume":"122","author":"Rozenfeld","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2025.106797_bb0550","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1007\/s10545-009-1060-9","article-title":"Leukocyte perturbation associated with Fabry disease","volume":"32","author":"Rozenfeld","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"issue":"7","key":"10.1016\/j.nbd.2025.106797_bb0555","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"issue":"4","key":"10.1016\/j.nbd.2025.106797_bb0560","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/jimd.12373","article-title":"Defective lysosomal storage in Fabry disease modifies mitochondrial structure, metabolism and turnover in renal epithelial cells","volume":"44","author":"Schumann","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.nbd.2025.106797_bb0565","article-title":"Use of the open field maze to measure locomotor and anxiety-like behavior in mice","volume":"96","author":"Seibenhener","year":"2015","journal-title":"J. Vis. Exp."},{"issue":"5","key":"10.1016\/j.nbd.2025.106797_bb0570","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12058","article-title":"Extracellular vesicles from recombinant cell factories improve the activity and efficacy of enzymes defective in lysosomal storage disorders","volume":"10","author":"Seras-Franzoso","year":"2021","journal-title":"J. Extracell Vesicles."},{"issue":"7","key":"10.1016\/j.nbd.2025.106797_bb0575","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/arclin\/acu047","article-title":"Cognitive and psychological functioning in Fabry disease","volume":"29","author":"Sigmundsdottir","year":"2014","journal-title":"Arch. Clin. Neuropsychol."},{"issue":"3","key":"10.1016\/j.nbd.2025.106797_bb0580","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/STROKEAHA.108.526293","article-title":"Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry registry","volume":"40","author":"Sims","year":"2009","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.nbd.2025.106797_bb0585","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1176\/jnp.23.4.jnp425","article-title":"Psychiatric manifestations of voltage-gated potassium-channel complex autoimmunity","volume":"23","author":"Somers","year":"2011","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2025.106797_bb0590","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am. J. Hum. Genet."},{"issue":"11","key":"10.1016\/j.nbd.2025.106797_bb0595","doi-asserted-by":"crossref","DOI":"10.3390\/cells11111730","article-title":"Dysregulation of immune response mediators and pain-related ion channels is associated with pain-like behavior in the GLA KO mouse model of Fabry disease","volume":"11","author":"Spitzel","year":"2022","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.nbd.2025.106797_bb0600","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF00697017","article-title":"Neuropathological and biochemical studies in Fabry\u2019s disease","volume":"30","author":"Tabira","year":"1974","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.nbd.2025.106797_bb0605","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00690579","article-title":"Anderson-Fabry\u2019s disease: neuropathological and neurochemical investigation","volume":"56","author":"Tagliavini","year":"1982","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.nbd.2025.106797_bb0610","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/BJ20130825","article-title":"A symptomatic Fabry disease mouse model generated by inducing globotriaosylceramide synthesis","volume":"456","author":"Taguchi","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2025.106797_bb0615","article-title":"Distinctive accumulation of globotriaosylceramide and globotriaosylsphingosine in a mouse model of classic Fabry disease","volume":"34","author":"Taguchi","year":"2023","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"26","key":"10.1016\/j.nbd.2025.106797_bb0620","doi-asserted-by":"crossref","first-page":"8363","DOI":"10.1523\/JNEUROSCI.3216-08.2009","article-title":"Mice with altered myelin proteolipid protein gene expression display cognitive deficits accompanied by abnormal neuron-glia interactions and decreased conduction velocities","volume":"29","author":"Tanaka","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106797_bb0625","article-title":"Prevalence of cerebral small vessel disease in a Fabry disease cohort","volume":"29","author":"Tapia","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"6","key":"10.1016\/j.nbd.2025.106797_bb0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157052","article-title":"LAMP5 fine-Tunes GABAergic synaptic transmission in defined circuits of the mouse brain","volume":"11","author":"Tiveron","year":"2016","journal-title":"PLoS One"},{"issue":"33","key":"10.1016\/j.nbd.2025.106797_bb0635","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.2174\/13816128113199990387","article-title":"Neurological complications of Anderson-Fabry disease","volume":"19","author":"Tuttolomondo","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"18","key":"10.1016\/j.nbd.2025.106797_bb0640","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221810088","article-title":"Pathogenesis and molecular mechanisms of Anderson-Fabry disease and possible new molecular addressed therapeutic strategies","volume":"22","author":"Tuttolomondo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.106797_bb0645","doi-asserted-by":"crossref","DOI":"10.1177\/1744806916646379","article-title":"Comprehensive and differential long-term characterization of the alpha-galactosidase a deficient mouse model of Fabry disease focusing on the sensory system and pain development","volume":"12","author":"Uceyler","year":"2016","journal-title":"Mol. Pain"},{"issue":"11","key":"10.1016\/j.nbd.2025.106797_bb0650","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1093\/brain\/awaa282","article-title":"White matter integrity correlates with cognition and disease severity in Fabry disease","volume":"143","author":"Ulivi","year":"2020","journal-title":"Brain"},{"issue":"1\u20132","key":"10.1016\/j.nbd.2025.106797_bb0655","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jns.2009.02.319","article-title":"Thrombosis in Japanese patients with Fabry disease","volume":"283","author":"Utsumi","year":"2009","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.nbd.2025.106797_bb0660","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.neuron.2018.04.018","article-title":"On how the dentate gyrus contributes to memory discrimination","volume":"98","author":"van Dijk","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.106797_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynpai.2021.100074","article-title":"Sensory-specific peripheral nerve pathology in a rat model of Fabry disease","volume":"10","author":"Waltz","year":"2021","journal-title":"Neurobiol. Pain."},{"key":"10.1016\/j.nbd.2025.106797_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2021.100358","article-title":"Activation of 6-8-week-old new mature adult-born dentate granule cells contributes to anxiety-like behavior","volume":"15","author":"Wang","year":"2021","journal-title":"Neurobiol. Stress."},{"issue":"3","key":"10.1016\/j.nbd.2025.106797_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107692","article-title":"Screening for health-related quality of life and its determinants in Fabry disease: a cross-sectional multicenter study","volume":"140","author":"Winter","year":"2023","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.nbd.2025.106797_bb0680","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)."},{"issue":"4","key":"10.1016\/j.nbd.2025.106797_bb0685","doi-asserted-by":"crossref","first-page":"541","DOI":"10.5498\/wjp.v12.i4.541","article-title":"Abnormal synaptic plasticity and impaired cognition in schizophrenia","volume":"12","author":"Wu","year":"2022","journal-title":"World J. Psychiatr."},{"issue":"1","key":"10.1016\/j.nbd.2025.106797_bb0690","doi-asserted-by":"crossref","first-page":"15277","DOI":"10.1038\/s41598-019-51805-6","article-title":"Circulating microRNAs in Fabry disease","volume":"9","author":"Xiao","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.nbd.2025.106797_bb0695","doi-asserted-by":"crossref","first-page":"590","DOI":"10.14336\/AD.2017.0430","article-title":"Age-related impairment of vascular structure and functions","volume":"8","author":"Xu","year":"2017","journal-title":"Aging Dis."},{"issue":"9","key":"10.1016\/j.nbd.2025.106797_bb0700","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/hipo.20808","article-title":"Pattern separation deficits associated with increased hippocampal CA3 and dentate gyrus activity in nondemented older adults","volume":"21","author":"Yassa","year":"2011","journal-title":"Hippocampus"},{"issue":"6226","key":"10.1016\/j.nbd.2025.106797_bb0705","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1126\/science.aaa1934","article-title":"Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq","volume":"347","author":"Zeisel","year":"2015","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.nbd.2025.106797_bb0710","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2018.06.021","article-title":"Molecular architecture of the mouse nervous system","volume":"174","author":"Zeisel","year":"2018","journal-title":"Cell"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125000130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125000130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T07:50:58Z","timestamp":1774338658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125000130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":140,"alternative-id":["S0969996125000130"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106797","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anxiety-like behavior and altered hippocampal activity in a transgenic mouse model of Fabry disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106797","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106797"}}